Market Research Reports and Industry Reports

Age Related Macular Degeneration - Pipeline Review, H2 2017

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Age Related Macular Degeneration - Pipeline Review, H2 2017

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration - Pipeline Review, H2 2017, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape.

Age related macular degeneration is the most common reason for vision loss in people aged above 50. It results in depreciation of the macula that may lead to distorted or blurry central vision. The predisposing factors involved are age, smoking, sunlight, heredity etc. Symptoms include development of blind spot and hazy vision. The condition may be treated by photodynamic therapy, radiation therapy and medication such as anti-angiogenic drugs.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Age Related Macular Degeneration - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Age Related Macular Degeneration (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Age Related Macular Degeneration (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Age Related Macular Degeneration and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 27, 18, 4, 135, 29 and 4 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 16 and 2 molecules, respectively.

Age Related Macular Degeneration (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Age Related Macular Degeneration (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Age Related Macular Degeneration (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Age Related Macular Degeneration (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Age Related Macular Degeneration (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Age Related Macular Degeneration (Ophthalmology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Age Related Macular Degeneration (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Age Related Macular Degeneration (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 6
Age Related Macular Degeneration - Overview 7
Age Related Macular Degeneration - Therapeutics Development 8
Age Related Macular Degeneration - Therapeutics Assessment 37
Age Related Macular Degeneration - Companies Involved in Therapeutics Development 51
Age Related Macular Degeneration - Drug Profiles 101
Age Related Macular Degeneration - Dormant Projects 487
Age Related Macular Degeneration - Discontinued Products 499
Age Related Macular Degeneration - Product Development Milestones 501
Appendix 511

List Of Tables


Number of Products under Development for Age Related Macular Degeneration, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Age Related Macular Degeneration - Pipeline by 3SBio Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Abzena Plc, H2 2017
Age Related Macular Degeneration - Pipeline by Achillion Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Aciont Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Acucela Inc, H2 2017
Age Related Macular Degeneration - Pipeline by AdAlta Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Adverum Biotechnologies Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Aerie Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Aerpio Therapeutics Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Alimera Sciences Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Alkeus Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Allergan Plc, H2 2017
Age Related Macular Degeneration - Pipeline by Allgenesis Biotherapeutics Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Allinky Biopharma, H2 2017
Age Related Macular Degeneration - Pipeline by Alteogen Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Amarna Therapeutics BV, H2 2017
Age Related Macular Degeneration - Pipeline by Apellis Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Apexigen Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Applied Genetic Technologies Corp, H2 2017
Age Related Macular Degeneration - Pipeline by Ascentage Pharma Group Corp Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Astellas Pharma Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Benitec Biopharma Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Biokine Therapeutics Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by BioMAS Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Biomics Biotechnologies Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Biophytis SAS, H2 2017
Age Related Macular Degeneration - Pipeline by Caladrius Biosciences Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Catalyst Biosciences Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Cell Cure Neurosciences Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Cell Medica Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Charlesson LLC, H2 2017
Age Related Macular Degeneration - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2017
Age Related Macular Degeneration - Pipeline by CJ HealthCare Corp, H2 2017
Age Related Macular Degeneration - Pipeline by Clanotech AB, H2 2017
Age Related Macular Degeneration - Pipeline by Coherus BioSciences Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Colby Pharmaceutical Co, H2 2017
Age Related Macular Degeneration - Pipeline by Crinetics Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Daiichi Sankyo Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Diffusion Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Dong-A Socio Holdings Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Eleven Biotherapeutics Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Elsalys Biotech SAS, H2 2017
Age Related Macular Degeneration - Pipeline by Enzene Biosciences Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Exonate Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by EyeGate Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Eyevensys SAS, H2 2017
Age Related Macular Degeneration - Pipeline by F. Hoffmann-La Roche Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by FirstString Research Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Foamix Pharmaceuticals Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Formycon AG, H2 2017
Age Related Macular Degeneration - Pipeline by Gene Techno Science Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Genentech Inc, H2 2017
Age Related Macular Degeneration - Pipeline by GenSight Biologics SA, H2 2017
Age Related Macular Degeneration - Pipeline by Graybug Vision Inc, H2 2017
Age Related Macular Degeneration - Pipeline by HanAll Biopharma Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Huabo Biopharm Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Icon Bioscience Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Iconic Therapeutics Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Ildong Pharmaceutical Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Inception Sciences Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Innovent Biologics Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Intellect Neurosciences Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Ionis Pharmaceuticals Inc, H2 2017
Age Related Macular Degeneration - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2017
Age Related Macular Degeneration - Pipeline by Johnson & Johnson, H2 2017

List Of Figures


Number of Products under Development for Age Related Macular Degeneration, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017

Asia-Pacific Surgery Medical Bandage Market Report 2018

In this report, the Asia-Pacific Surgery Medical Bandage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

USD 4000View Report

Asia-Pacific Sports Beverages Market Report 2018

In this report, the Asia-Pacific Sports Beverages market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

USD 4000View Report

Global Age Related Macular Degeneration Drug Market Research Report 2017

In this report, the global Age Related Macular Degeneration Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end

USD 2900View Report

EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2026

EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2026Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is

USD 3995View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprise Wide Licence    USD 6000
$ 2000

Reports Details

Published Date : Dec 2017
No. of Pages :537
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube